SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001088875-21-000050
Filing Date
2021-01-28
Accepted
2021-01-28 06:36:33
Documents
1

Document Format Files

Seq Description Document Type Size
1 Adaptimmune31122020.txt SC 13G 9813
  Complete submission text file 0001088875-21-000050.txt   11452
Mailing Address CALTON SQUARE 1 GREENSIDE ROW EDINBURGH X0 EH13AN
Business Address CALTON SQUARE 1 GREENSIDE ROW EDINBURGH X0 EH13AN 00441312752000
BAILLIE GIFFORD & CO (Filed by) CIK: 0001088875 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0
Type: SC 13G

Mailing Address 60 JUBILEE AVENUE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RX
Business Address 60 JUBILEE AVENUE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RX 44 1235 430000
Adaptimmune Therapeutics PLC (Subject) CIK: 0001621227 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-88833 | Film No.: 21561978
SIC: 2836 Biological Products, (No Diagnostic Substances)